3 Ways Your Medicare Advantage Plan May Have Changed This Year

Medicare Advantage plans can change year-to-year and beneficiaries should review 2026 plan notices: premiums, deductibles, coinsurance and copays may rise, supplemental benefits (dental, vision, hearing, home cleaning, meal delivery) can be added or removed, and provider networks may change. Enrollees have until March 31 to switch plans or revert to original Medicare, a window that could trigger membership shifts among insurers if changes increase costs or reduce access for affected beneficiaries.

Analysis

Market structure: Medicare Advantage plan churn (higher premiums, benefit/network changes) structurally favors large MA payors (UNH, HUM, ELV, CVS) who can reprice, narrow networks and cross-sell ancillary services; hospitals and independent specialists (HCA, Tenet) are losers as steering reduces billed volumes and unit pricing. Expect MA-insurer pricing power to increase margins by 100–300bps over 12–24 months if enrollment continues migrating; provider leverage and spot hospital utilization are the pressured supply side.

Risk assessment: Key tail risks are CMS policy reversals (benchmark cuts >1–2%), class-action network adequacy suits, or faster-than-expected enrollee churn if out-of-pocket rises >5% — each could erase projected margin gains within 3–6 months. Near-term (days–weeks) catalyst is the Mar 31 enrollment window and Q1 benefit filings; medium-term (quarters) risk is wage inflation for home-based care raising supplemental benefit costs.

Trade implications: Tactical bias long large MA insurers and ancillary providers that sell to plans (dental/hearing chains), and short select hospital operators and healthcare REITs with high Medicare exposure. Specific vehicles: buy 12-month call spreads on UNH/HUM, fund them with put spreads on HCA/TENET-sized to limit capital; rotate toward managed-care ETFs (e.g., IHF) and away from hospital ETFs (e.g., XHB) over 1–12 months, entering before Mar 31 to capture enrollment momentum.

Contrarian angles: Consensus underprices consolidation/ancillary M&A upside — insurers may buy dental/hearing/homecare assets, creating TMT-like vertical integration and upside M&A near-term (6–18 months). Conversely, the market may be underestimating short-term churn and regulatory scrutiny — if CMS tightens benefits reimbursement or network rules, insurers’ 12–24 month forecasts will reprice down sharply.

Key Decisions for Investors

• Establish a 3% portfolio long position allocated 40% UNH, 30% HUM, 30% ELV over next 1–3 months; target +20% price appreciation in 12 months, set hard stop-loss at -10%.
• Initiate a 1.5–2% short exposure to hospital operators via equal-weight HCA and Tenet (ticker THC) using 3–6 month put spreads (limit max premium = 0.8% notional) to hedge downside from MA steering; target -15% relative move in 3–12 months.
• Buy 12-month call spreads on UNH and HUM (≈10% OTM, capped width) sized to 0.6% notional each to capture upside with limited capital; fund by selling 3–6 month out-of-the-money put spreads on HCA to monetize near-term downside risk.
• Monitor CMS/Medicare Advantage benchmark notices and plan benefit files between Mar 1–Apr 30: if CMS cuts benchmarks >1% or an insurer reports enrollment down >2% QoQ, reduce insurer longs by 50% within 5 trading days and reallocate to cash/short hospital exposure.